Abstract
Induced fit docking approach was utilized to decipher the binding mode of the recently reported dibenz[b,f]1,5- oxazocine derivative having activity towards κ -Opioid receptor. The result of docking to newly resolved crystallographic structure of κ -Opioid receptor established the important interactions as two hydrogen bonds, a π-π interaction, and two hydrophobic interactions. Based on the study it is inferred that protonated nitrogen is not always essential for binding of non-peptidic nitrogen containing opioids to κ -Opioid receptor. Also, docking was performed using well-known kappa agonist pentazocine to prove different binding requirements of the dibenzo compound. A pharmacophoric model has been developed based on the previously known nitrogen containing κ -Opioid receptor agonists and the new dibenzo compound to determine the minimal 3D features, required for κ -Opioid agonist activity. To our knowledge, this is the first report of a binding mode analysis study for non-protonated nitrogen containing κ-Opioid receptor agonist.
Keywords: Agonist, Docking, Kappa opioid receptor, Non-peptidic, Opioids, Protonated nitrogen.
Letters in Drug Design & Discovery
Title:Positively Charged Nitrogen is Not Indispensable Requirement for Binding of Nitrogenous κ-Opioid Agonists: Insights from Docking Studies
Volume: 11 Issue: 6
Author(s): Indrani Bera and Nanda Ghoshal
Affiliation:
Keywords: Agonist, Docking, Kappa opioid receptor, Non-peptidic, Opioids, Protonated nitrogen.
Abstract: Induced fit docking approach was utilized to decipher the binding mode of the recently reported dibenz[b,f]1,5- oxazocine derivative having activity towards κ -Opioid receptor. The result of docking to newly resolved crystallographic structure of κ -Opioid receptor established the important interactions as two hydrogen bonds, a π-π interaction, and two hydrophobic interactions. Based on the study it is inferred that protonated nitrogen is not always essential for binding of non-peptidic nitrogen containing opioids to κ -Opioid receptor. Also, docking was performed using well-known kappa agonist pentazocine to prove different binding requirements of the dibenzo compound. A pharmacophoric model has been developed based on the previously known nitrogen containing κ -Opioid receptor agonists and the new dibenzo compound to determine the minimal 3D features, required for κ -Opioid agonist activity. To our knowledge, this is the first report of a binding mode analysis study for non-protonated nitrogen containing κ-Opioid receptor agonist.
Export Options
About this article
Cite this article as:
Bera Indrani and Ghoshal Nanda, Positively Charged Nitrogen is Not Indispensable Requirement for Binding of Nitrogenous κ-Opioid Agonists: Insights from Docking Studies, Letters in Drug Design & Discovery 2014; 11 (6) . https://dx.doi.org/10.2174/1570180811666140220004853
DOI https://dx.doi.org/10.2174/1570180811666140220004853 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Ambivalent Role of Apoptosis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Current Pharmaceutical Design Reductive Stress: A New Concept in Alzheimer’s Disease
Current Alzheimer Research Therapeutic Implications of Superoxide Dismutase And Its Importance in Kinase Drug Discovery
Current Topics in Medicinal Chemistry Pro-inflammatory Cytokines Modulate Glial Apolipoprotein E Secretion
Current Alzheimer Research Recent Innovations in the Area of Edible Films and Coatings
Recent Patents on Food, Nutrition & Agriculture Non Genomic Modulation of Ligand Gated Ionotropic Receptors by Thyroid Hormones
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Peripheral and Dual Binding Site Acetylcholinesterase Inhibitors: Implications in treatment of Alzheimers Disease
Mini-Reviews in Medicinal Chemistry Applications of Exosomes in Targeted Drug Delivery for the Treatment of Parkinson’s Disease: A Review of Recent Advances and Clinical Challenges
Current Topics in Medicinal Chemistry Innate Inflammatory Responses in Stroke: Mechanisms and Potential Therapeutic Targets
Current Medicinal Chemistry Association of rs610932 and rs670139 Polymorphisms in the MS4A Gene Cluster with Alzheimer’s Disease: An Updated Meta-analysis
Current Alzheimer Research The Effect of Stress Management Program on Perceived Stress in Patients with Type 2 Diabetes: A Randomized Controlled Trial
Current Diabetes Reviews Targeting T-Cell Adhesion Molecules for Drug Design
Current Pharmaceutical Design Advanced Glycation End Products, Oxidative Stress and Metalloproteinases are altered in the Cerebral Microvasculature during Aging
Current Neurovascular Research The Role of Xanthine Oxidase Inhibitors in Patients with History of Stroke: A Systematic Review
Current Vascular Pharmacology Role of Autophagy in Parkinson’s Disease
Current Medicinal Chemistry Safety and Efficacy of Levetiracetam for the Management of Levodopa- Induced Dyskinesia in Patients with Parkinson’s Disease: A Systematic Review
CNS & Neurological Disorders - Drug Targets Immunomodulation in Trichinellosis: Does Trichinella Really Escape the Host Immune System?
Endocrine, Metabolic & Immune Disorders - Drug Targets Behavioral Effects of 2,3-Dihydro- and Oxoisoaporphine Derivatives in Post Stroke-Depressive Like Behavior in Male Balb/c Mice
Current Topics in Medicinal Chemistry 6-hydroxydopamine Lesion of the Mesolimbic Dopamine System Alters Morphine-Induced Conditioned Reinforcement
Current Psychopharmacology Opioid Regulation of Mu Receptor Internalisation: Relevance to the Development of Tolerance and Dependence
CNS & Neurological Disorders - Drug Targets